PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse

Targeted Oncology

  • h-index: 69
  • Total citations: 22,840
  • Total papers: 946
  • Impact factor: 3.7579617834394905

Homepage: https://www.springer.com/journal/11523

Targeted Oncology

Journal
Visit website →
H-Index = 69
Citations = 22.84K+

Papers

Evidence

Recent papers in Targeted Oncology

  1. One-Week Inflammatory Kinetics After First-Line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma: A Multicenter Landmark AnalysisTargeted Oncology · Mon,
  2. Outcomes by Body Mass Index in Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Treated with Inotuzumab OzogamicinTargeted Oncology · Wed,
  3. Management of Adverse Events Associated with MET TKIs in Patients with Advanced NSCLC: A Podcast DiscussionTargeted Oncology · Sat,
  4. Risk of Recurrence in Patients with HR+/HER2− Early Breast Cancer: A PodcastTargeted Oncology · Mon,
  5. Clinical Pharmacology of Lisocabtagene Maraleucel in B-cell MalignanciesTargeted Oncology · Tue,
  6. Rare Molecular Variants of Gastrointestinal Stromal Tumors (GISTs): Clinical Implications and Overview of Current EvidenceTargeted Oncology · Wed,
  7. Impact of PSA Nadir on Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysisTargeted Oncology · Fri,
  8. Subcutaneous Amivantamab and Lazertinib in PALOMA-3: Efficacy, Safety, and Administration: A VodcastTargeted Oncology · Thu,
  9. P-VERIFY: Real-World Comparative Overall Survival and Progression-Free Survival of CDK4/6 Inhibitors Plus an Aromatase Inhibitor in Patients with HR+/HER2− Metastatic Breast Cancer in the USA—A VodcastTargeted Oncology · Thu,
  10. CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms, Resistance, and Emerging OpportunitiesTargeted Oncology · Thu,

About Targeted Oncology

Targeted Oncology carries 946 indexed papers, 22,840 citations, h-index 69 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Targeted Oncology sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at https://www.springer.com/journal/11523.

Use the feed below to follow new Targeted Oncology publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 102 words.